Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03110302 · ClinicalTrials.gov registry record · NA

In-Home Exposure Therapy for Veterans With Post Traumatic Stress Disorder (PTSD)

A NA study of Post Traumatic Stress Disorder, sponsored by Veterans Medical Research Foundation.

Completed
Registry status
NA
Development phase
175
Enrollment target
1
Study location

NCT03110302: Completed NA study of Post Traumatic Stress Disorder, sponsored by Veterans Medical Research Foundation.

NCT03110302 is a NA study of Post Traumatic Stress Disorder that has completed, run by Veterans Medical Research Foundation. The registered enrollment target is 175 participants, below the 663-participant average among 262 other Post Traumatic Stress Disorder trials with a reported enrollment target (74% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03110302, a NA study of Post Traumatic Stress Disorder, has completed, sponsored by Veterans Medical Research Foundation.

COMPLETED
Registry status
NA
Development phase
175 participants
Enrollment target
1
Study location

Study Summary

This study examines clinical and process outcomes following variable length prolonged exposure (PE) for posttraumatic stress disorder (PTSD) delivered by one of three treatment modalities: home-based telehealth (HBT), office-based telehealth (OBT), or in-home-in-person (IHIP).

Primary Outcome

The CAPS is a clinician-administered interview that assesses PTSD severity and diagnostic threshold. CAPS questions are designed to assess DSM-5 PTSD diagnostic criteria. CAPS has become the "gold standard" semistructured interview for assessing PTSD in the general population.

Interventions

  • BEHAVIORAL Prolonged exposure

Study Locations (1)

California

  • VA San Diego Healthcare System - San Diego

Trial Details

FieldValue
Enrollment Target 175 participants
Start Date 2012-10
Est. Completion 2018-07
Phase NA

What the finished NCT03110302 record still lists

NCT03110302 is an interventional study that assigns participants to a tested intervention. The registered 175 participants enrollment target is mid-sized for trials with a published cap, below the 663-participant average among 262 other Post Traumatic Stress Disorder trials with a reported enrollment target (74% lower).

The record links to 1 condition, with Post Traumatic Stress Disorder appearing as the primary indexed condition, and to 1 intervention - of which Prolonged exposure is the first listed.

NCT03110302 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT03110302 about?

NCT03110302 is a clinical study titled "In-Home Exposure Therapy for Veterans With Post Traumatic Stress Disorder (PTSD)". This study examines clinical and process outcomes following variable length prolonged exposure (PE) for posttraumatic stress disorder (PTSD) delivered by one of three treatment modalities: home-based telehealth (HBT), office-based telehealth (OBT), or in-home-in-person (IHIP).

What is the current status of trial NCT03110302?

This trial is currently completed. It is a NA study. The enrollment target is 175 participants. The study started on 2012-10. Estimated completion is 2018-07.

What conditions does trial NCT03110302 study?

This clinical trial studies the following conditions: Post Traumatic Stress Disorder.

What interventions are being tested in trial NCT03110302?

The interventions under investigation include: Prolonged exposure (BEHAVIORAL).

Who is sponsoring clinical trial NCT03110302?

This trial is sponsored by Veterans Medical Research Foundation, which has 35 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03110302 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Post Traumatic Stress Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03110302's enrollment target sits among peer trials

175 68th of 262 higher than 194 of 262 other Post Traumatic Stress Disorder trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Post Traumatic Stress Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04722341 · 175 participants · NA

    Time-Restricted Eating and Cancer: Clinical Outcomes, Mechanisms, and Moderators

  • NCT05094037 · 175 participants · NA

    Orthotic Treatment of Diabetic Foot Ulcers

  • NCT05165745 · 175 participants · NA

    Stick2PrEP Cisgender Women and Trans Individuals

  • NCT05312255 · 175 participants · NA

    Non-chemotherapeutic Interventions for the Improvement of Quality of Life and Immune Function in Patients With Multiple Myeloma

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT03110302, the US trial registry maintained by the National Library of Medicine. NCT03110302 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.